Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy such as perifosine use different ways to stop tumor
cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of perifosine in treating patients who
have prostate cancer that no longer responds to androgen ablation therapy.